Company · CIK 0000849146 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Lifevantage Corp · LFVN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 PForm 4 → | Sep 17, 4:05 pm EDT | Darwin LewisDirector | 976 | $6.22 | $6,071 | 138,244 | +0.71% | 10b5-1 |
| Sep 11, 2026 SForm 4 → | Sep 14, 6:55 pm EDT | Kristen CunninghamChief Sales Officer | 9,001 | $6.18 | $55,649 | 120,162 | −6.97% | |
| Sep 10, 2026 FForm 4 → | Sep 14, 6:56 pm EDT | Carl AureChief Financial Officer | 1,869 | $6.37 | $11,906 | 156,495 | — | |
| Sep 10, 2026 FForm 4 → | Sep 14, 6:55 pm EDT | Kristen CunninghamChief Sales Officer | 2,254 | $6.37 | $14,358 | 129,163 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.